EX-23.1 2 f10k2023a1ex23-1_inmedphar.htm CONSENT OF MARCUM LLP

Exhibit 23.1


Independent Registered Public Accounting Firm’s Consent


We consent to the incorporation by reference in this Registration Statement of InMed Pharmaceuticals Inc. on Forms S-1 [File Nos. 333-253925, 333-257858, 333-265731, 333-267831 and 333-268700], on Forms S-3 [File Nos. 333-262533 and 333-264187], and on Forms S-8 [File Nos. 333-253912, 333-260323, and 333-268356] of our report dated September 29, 2023, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern with respect to our audit of the consolidated financial statements of InMed Pharmaceuticals Inc. as of June 30, 2023 and for the year then ended, appearing in the Annual Report on Form 10-K of InMed Pharmaceuticals Inc. for the year ended June 30, 2023.


/s/ Marcum llp


Marcum llp

New York, NY

December 21, 2023